Friday, October 23, 2020 10:16:08 AM
2 reasons.
1. Redemsivir approval
2. Another VIP company closing shop on A VIP drug trial .
To lesser knowledgeable investors this PhaseBio's Vip derivative is the same as RLFTF, but it isn't. And apparently the form isn't nuetralizing COVID or it's form is fine but SUBQ delivery isn't a viable delivery for the hormone?
1. Redemsivir approval
2. Another VIP company closing shop on A VIP drug trial .
To lesser knowledgeable investors this PhaseBio's Vip derivative is the same as RLFTF, but it isn't. And apparently the form isn't nuetralizing COVID or it's form is fine but SUBQ delivery isn't a viable delivery for the hormone?
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
